Suppr超能文献

固体核磁共振研究吲哚美辛-乙基纤维素 E 无定形固体分散体中药物-赋形剂相互作用和相行为。

Solid-State NMR Investigation of Drug-Excipient Interactions and Phase Behavior in Indomethacin-Eudragit E Amorphous Solid Dispersions.

机构信息

Small Molecule Pharmaceutical Sciences, Genentech, Inc., 1 DNA Way, South San Francisco, California, 94080, USA.

出版信息

Pharm Res. 2018 Feb 20;35(3):65. doi: 10.1007/s11095-018-2364-y.

Abstract

PURPOSE

To investigate the nature of drug-excipient interactions between indomethacin (IMC) and methacrylate copolymer Eudragit® E (EE) in the amorphous state, and evaluate the effects on formulation and stability of these amorphous systems.

METHODS

Amorphous solid dispersions containing IMC and EE were spray dried with drug loadings from 20% to 90%. PXRD was used to confirm the amorphous nature of the dispersions, and DSC was used to measure glass transition temperatures (T). C and N solid-state NMR was utilized to investigate changes in local structure and protonation state, while H T and T relaxation measurements were used to probe miscibility and phase behavior of the dispersions.

RESULTS

T values for IMC-EE solid dispersions showed significant positive deviations from predicted values in the drug loading range of 40-90%, indicating a relatively strong drug-excipient interaction. N solid-state NMR exhibited a change in protonation state of the EE basic amine, with two distinct populations for the EE amine at -360.7 ppm (unprotonated) and -344.4 ppm (protonated). Additionally, H relaxation measurements showed phase separation at high drug load, indicating an amorphous ionic complex and free IMC-rich phase. PXRD data showed all ASDs up to 90% drug load remained physically stable after 2 years.

CONCLUSIONS

N solid-state NMR experiments show a change in protonation state of EE, indicating that an ionic complex indeed forms between IMC and EE in amorphous solid dispersions. Phase behavior was determined to exhibit nanoscale phase separation at high drug load between the amorphous ionic complex and excess free IMC.

摘要

目的

研究吲哚美辛(IMC)与甲基丙烯酸共聚物 Eudragit® E(EE)在无定形状态下的药物-赋形剂相互作用的性质,并评估这些无定形系统对制剂和稳定性的影响。

方法

用载药量为 20%至 90%的喷雾干燥法制备含有 IMC 和 EE 的无定形固体分散体。粉末 X 射线衍射(PXRD)用于确认分散体的无定形性质,差示扫描量热法(DSC)用于测量玻璃化转变温度(T)。C 和 N 固态 NMR 用于研究局部结构和质子化状态的变化,而 H T 和 T 弛豫测量用于探测分散体的混溶性和相行为。

结果

IMC-EE 固体分散体的 T 值在 40-90%的载药量范围内表现出明显的正偏差,表明存在相对较强的药物-赋形剂相互作用。N 固态 NMR 显示 EE 碱性胺的质子化状态发生变化,EE 胺在-360.7 ppm(未质子化)和-344.4 ppm(质子化)处出现两个明显的峰。此外,H 弛豫测量表明在高药物载量下发生相分离,表明存在无定形离子络合物和游离 IMC 富相。PXRD 数据表明,所有载药量高达 90%的 ASD 在 2 年后仍保持物理稳定性。

结论

N 固态 NMR 实验表明 EE 的质子化状态发生变化,表明 IMC 和 EE 确实在无定形固体分散体中形成离子络合物。相行为确定在高药物载量下,无定形离子络合物和过量游离 IMC 之间存在纳米级相分离。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验